CAD 0.02
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 2.02 Million CAD | 3.58% |
2022 | 1.95 Million CAD | -7.12% |
2021 | 2.1 Million CAD | -2.54% |
2020 | 2.16 Million CAD | -63.8% |
2019 | 5.97 Million CAD | 2388.75% |
2018 | 240 Thousand CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 Q4 | 2.02 Million CAD | 0.7% |
2023 Q3 | 2.01 Million CAD | 1.0% |
2023 Q2 | 1.99 Million CAD | 0.81% |
2023 Q1 | 1.97 Million CAD | 1.02% |
2022 Q1 | 1.87 Million CAD | -11.11% |
2022 Q4 | 1.95 Million CAD | 3.16% |
2022 Q3 | 1.89 Million CAD | 0.26% |
2022 Q2 | 1.89 Million CAD | 1.01% |
2021 Q1 | 2.08 Million CAD | 0.0% |
2021 Q4 | 2.1 Million CAD | 0.33% |
2021 Q3 | 2.1 Million CAD | 0.29% |
2021 Q2 | 2.09 Million CAD | 0.48% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 5.06 Million CAD | 59.971% |
CanadaBis Capital Inc. | 7.3 Million CAD | 72.268% |
Decibel Cannabis Company Inc. | 40.96 Million CAD | 95.052% |
Entourage Health Corp. | 161.58 Million CAD | 98.746% |
Lifeist Wellness Inc. | 1.26 Million CAD | -60.109% |
Cannara Biotech Inc. | 45.78 Million CAD | 95.573% |
Medicure Inc. | 544 Thousand CAD | -272.61% |
PharmaCielo Ltd. | 18.3 Million CAD | 88.929% |
Rubicon Organics Inc. | 10.25 Million CAD | 80.243% |
BioSyent Inc. | 1.22 Million CAD | -66.005% |
Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -4967.5% |